Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Serological responses of Gambian children to immunization with the malaria vaccine SPf66.
Metzger, WG; Haywood, M; D'ALESSANDRO, U; DRAKELEY, CJ; WEISS, H; BOJANG, K; Targett, GA; GREENWOOD, BM;
2002
Parasite immunology, (2002).21 7 10.1046/j.1365-3024.1999.00231.x.
Immune responses to Plasmodium falciparum antigens during a malaria vaccine trial in Tanzanian children.
Alonso, PL; Lopez, MC; Bordmann, G; Smith, TA; Aponte, JJ; Weiss, NA; Urassa, H; Armstrong-Schellenberg, JR; Kitua, AY; Masanja, H; Thomas, MC; Oettli, A; Hurt, N; HAYES, R; Kilama, WL; Tanner, M;
2002
Parasite immunology, (2002).20 2 10.1046/j.1365-3024.1998.00125.x.
Patterns of helminth infection and relationship to BCG vaccination in Karonga District, northern Malawi.
Randall, AE; Perez, MA; FLOYD, S; Black, GF; CRAMPIN, AC; Ngwira, B; Pistoni, WN; Mulawa, D; Sichali, L; Mwaungulu, L; BICKLE, Q; FINE, PE M;
2002
Transactions of the Royal Society of Tropical Medicine and Hygiene, (2002).96 1 10.1016/s0035-9203(02)90229-4.
Prevention of otitis media by vaccination.
Russell, F; MULHOLLAND, K;
2002
Drugs, (2002).62 10 10.2165/00003495-200262100-00002.
Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis.
Beutels, P; EDMUNDS, WJ; Antoñanzas, F; De Wit, GA; Evans, D; Feilden, R; Fendrick, AM; Ginsberg, GM; Glick, HA; Mast, E; Péchevis, M; Van Doorslaer, EK A; Van Hout, BA; Viral Hepatitis Prevention Board,;
2002
PharmacoEconomics, (2002).20 1 10.2165/00019053-200220010-00001.
Sulphatide-binding properties are shared by serum amyloid P component and a polyreactive germ-line IgM autoantibody, the TH3 idiotype.
Wheeler, PR; RAYNES, JG; O'Sullivan, GM; Duggan, D; McAdam, KP;
2001
Clinical and experimental immunology, (2001).112 2 10.1046/j.1365-2249.1998.00593.x.
Humoral immune responses during a malaria vaccine trial in Tanzanian infants.
Galindo, CM; Acosta, CJ; SCHELLENBERG, D; Schellenberg, D; Aponte, JJ; ROCA, A; Oettli, A; Urassa, H; ARMSTRONG SCHELLENBERG, J; Kahigwa, E; Ascaso, C; Mshinda, H; Lwilla, F; Vidal, J; Menendez, C; Tanner, M; Alonso, PL;
2001
Parasite immunology, (2001).22 9 10.1046/j.1365-3024.2000.00322.x.
Dominant recognition of a cross-reactive B-cell epitope in Mycobacterium leprae 10 K antigen by immunoglobulin G1 antibodies across the disease spectrum in leprosy.
Hussain, R; DOCKRELL, HM; Chiang, TJ;
2001
Immunology, (2001).96 4 10.1046/j.1365-2567.1999.00740.x.
Selective correlation of interferon-gamma, tumour necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor with immunoglobulin G1 and immunoglobulin G3 subclass antibody in leprosy.
Hussain, R; Kifayet, A; Dojki, M; DOCKRELL, HM;
2001
Immunology, (2001).98 2 10.1046/j.1365-2567.1999.00876.x.
Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial.
BOJANG, KA; MILLIGAN, PJ; Pinder, M; Vigneron, L; Alloueche, A; Kester, KE; Ballou, WR; CONWAY, DJ; Reece, WH; Gothard, P; Yamuah, L; Delchambre, M; Voss, G; GREENWOOD, BM; Hill, A; McAdam, KP; Tornieporth, N; Cohen, JD; Doherty, T; RTS, S Malaria Vaccine Trial Team,;
2001
Lancet, (2001).358 9297 10.1016/S0140-6736(01)06957-4.